1997
DOI: 10.1006/dbio.1997.8764
|View full text |Cite
|
Sign up to set email alerts
|

The Effects of Angiotensin II and Specific Angiotensin Receptor Blockers on Embryonic Cardiac Development and Looping Patterns

Abstract: The role of angiotensin II (Ang II) in the early embryonic development of the heart has not been examined. We have used RT-PCR to identify mRNA for angiotensinogen, angiotensin-converting enzyme, and the Ang II AT1 and AT2 receptors in embryonic day 10.25 Sprague-Dawley rats, and have used confocal microscopy to localize the AT1 receptor to the greater curvature of the developing ventricle in these animals at embryonic days (ED) 9.25 and 10.25. The antibodies used in immunolocalization studies did not distingu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
31
0

Year Published

2000
2000
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 53 publications
(32 citation statements)
references
References 57 publications
1
31
0
Order By: Relevance
“…The timing of the switch between AT2 and AT1 receptor predominance in fetal/neonatal heart may indicate a key stage of cardiac development susceptible to perturbations by unfavorable neonatal conditions. The latter is corroborated by studies showing that prenatal and early postnatal treatment with AT1 blockers and ACE inhibitors is associated with cardiac 22 and kidney 23,24 abnormal development. Cardiac hypertrophy and fibrosis and changes in Ang receptors have been reported in late fetal or young offspring subjected to deleterious fetal conditions [25][26][27] To our knowledge, no study beside our previous one 13 has reported cardiac expression of Ang receptors after neonatal hyperoxic exposure or other conditions associated with preterm infant environment.…”
Section: April 2016mentioning
confidence: 74%
“…The timing of the switch between AT2 and AT1 receptor predominance in fetal/neonatal heart may indicate a key stage of cardiac development susceptible to perturbations by unfavorable neonatal conditions. The latter is corroborated by studies showing that prenatal and early postnatal treatment with AT1 blockers and ACE inhibitors is associated with cardiac 22 and kidney 23,24 abnormal development. Cardiac hypertrophy and fibrosis and changes in Ang receptors have been reported in late fetal or young offspring subjected to deleterious fetal conditions [25][26][27] To our knowledge, no study beside our previous one 13 has reported cardiac expression of Ang receptors after neonatal hyperoxic exposure or other conditions associated with preterm infant environment.…”
Section: April 2016mentioning
confidence: 74%
“…We know from the literature that apoptosis participates in the intrauterus and early postgestational heart development 14,15 and that all the components of the renin-angiotensin system are expressed by the fetal heart and participate in its normal development. 16,17 Interestingly, a recent study from a coauthor of this article showed that the 3 Shc isoforms are activated in the human fetal heart, in a period that is characterized by apoptotic and proliferative processes. 15 In our opinion, the p66 Shc knock-out may interfere with the heart development by inhibiting the apoptotic and hypertrophic signaling emanating from AT 1 or other factors as well as enhancing the proliferation of cardiomyocyte and CPCs.…”
Section: Shc Isoformsmentioning
confidence: 98%
“…26 However, persistent upregulation of AT1 receptors later in life can lead to myocardial hypertrophy and changes in contractility. 27 In our study, upregulation of AT1 receptors could contribute to the development of cardiac remodeling and to cardiac compensating/decompensating responses during Ang II infusion in O 2 -exposed rats.…”
Section: 24mentioning
confidence: 99%